The Kick-Off Meeting of the PROFORMA project took place on 30th April 2018 at White Sands Resort and Conference Centre in Dar es Salaam, Tanzania. PROFORMA officially started on the 1st of March 2018 and this kick-off meeting served as the first General Assembly of the consortium to personally meet the participating partners and to update the consortium members on progress to date, future plans as well as discuss the communication strategy and activities of the project. 37 people representing national medicine regulatory authorities, research institutions, and scientific advisory board members and stakeholders from eight countries attended the meeting. The consortium of PROFORMA consists of 10 partner organizations from 4 East African and 2 Europeans countries.

The aim of this kick off meeting was to:

  • Develop a common understanding of the project objectives, tasks and expected results.
  • Discuss in detail the activities in the different work package with task planning and coordination of task contributions with emphasis on priority tasks.
  • Establish a common basis for the effective coordination of Project work and Partnership communication.
Members of the PROFORMA consortium and its scientific advisory board members

Photo: Members of the PROFORMA consortium and its scientific advisory board members.

We thank all participants and meeting organizers for making a very productive kick-off meeting possible and look ahead towards a busy first year!


The PROFORMA kick off meeting was arranged jointly with another EDCTP funded Consortium, PAVIA, to identify common activities and discuss possibilities for collaboration. The two consortia have mutually supportive objectives. During the joint kick off meeting, which was held during 30 April 2018 – 2 May 2018, members of the two consortia discussed overlapping areas, synergies, and joint work plan to maximize the impact and avoid duplication of efforts.

Members of the PROFORMA and PAVAIA consortium with their scientific advisory board members

Photo: Members of the PROFORMA and PAVIA consortium with their scientific advisory board members